Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Hoffmann

Showing results (221-230 of 312) with videos related to

Pageof 32
Sort By:
Cellular & Molecular Immunology|October 26, 2021
The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiencyPrerna Arora, Cheila Rocha, Amy Kempf, et al.
Nature Medicine|January 24, 2007
Dickkopf-1 is a master regulator of joint remodelingDanielle Diarra, Marina Stolina, Karin Polzer, et al.
Gigascience|May 3, 2023
TF-Prioritizer: a Java pipeline to prioritize condition-specific transcription factorsMarkus Hoffmann, Nico Trummer, Leon Schwartz, et al.
European Journal of Immunology|September 21, 2021
A surrogate cell-based SARS-CoV-2 spike blocking assayWolfgang Schuh, Lena Baus, Tobit Steinmetz, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|June 6, 2007
Determination of the triplet state energies of a series of conjugated porphyrin oligomersMarina K Kuimova, Markus Hoffmann, Mikael U Winters, et al.
Journal of Medical Virology|September 3, 2022
Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infectionLukas Wettstein, Patrick Immenschuh, Tatjana Weil, et al.
Cell Reports|October 6, 2021
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccinationPrerna Arora, Anzhalika Sidarovich, Nadine Krüger, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 20, 2020
Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2Dennis Lapuente, Clara Maier, Pascal Irrgang, et al.
Cell Host & Microbe|May 19, 2022
SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodiesPrerna Arora, Lu Zhang, Nadine Krüger, et al.
Cancer Letters|December 3, 2014
The antileukoprotease secretory leukocyte protease inhibitor (SLPI) and its role in the prevention of HPV-infections in head and neck squamous cell carcinomaElgar S Quabius, Tibor Görögh, Gerrit S Fischer, et al.
Pageof 32

Showing results (221-230 of 312) with videos related to

Sort By:
Pageof 32
Cellular & Molecular Immunology|October 26, 2021
The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiencyPrerna Arora, Cheila Rocha, Amy Kempf, et al.
Nature Medicine|January 24, 2007
Dickkopf-1 is a master regulator of joint remodelingDanielle Diarra, Marina Stolina, Karin Polzer, et al.
Gigascience|May 3, 2023
TF-Prioritizer: a Java pipeline to prioritize condition-specific transcription factorsMarkus Hoffmann, Nico Trummer, Leon Schwartz, et al.
European Journal of Immunology|September 21, 2021
A surrogate cell-based SARS-CoV-2 spike blocking assayWolfgang Schuh, Lena Baus, Tobit Steinmetz, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|June 6, 2007
Determination of the triplet state energies of a series of conjugated porphyrin oligomersMarina K Kuimova, Markus Hoffmann, Mikael U Winters, et al.
Journal of Medical Virology|September 3, 2022
Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infectionLukas Wettstein, Patrick Immenschuh, Tatjana Weil, et al.
Cell Reports|October 6, 2021
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccinationPrerna Arora, Anzhalika Sidarovich, Nadine Krüger, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 20, 2020
Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2Dennis Lapuente, Clara Maier, Pascal Irrgang, et al.
Cell Host & Microbe|May 19, 2022
SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodiesPrerna Arora, Lu Zhang, Nadine Krüger, et al.
Cancer Letters|December 3, 2014
The antileukoprotease secretory leukocyte protease inhibitor (SLPI) and its role in the prevention of HPV-infections in head and neck squamous cell carcinomaElgar S Quabius, Tibor Görögh, Gerrit S Fischer, et al.
Pageof 32